Drug profile

The FDA adverse-event record for Dextrose

244 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Dextrose. See the species affected, top reactions, and outcomes below.

244
adverse-event reports
63.5%
death-coded share
Dog
most-reported species
121
Hypoglycaemia - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
244
Total Reports
155
Deaths Reported
63.5%
Death Rate

Active Ingredients

Dextrose

Administration Routes

UnknownIntravenousParenteralOralSubcutaneousIntraperitonealOther

Species Affected

Dog 172
Cat 71
Rabbit 1

Most Affected Breeds

Domestic Shorthair 48
Retriever - Labrador 23
Chihuahua 11
Retriever - Golden 10
Terrier - Yorkshire 9
Papillon - Spaniel - Continental Toy (with erect ears or with dropped ears (Phaléne)) 6
Shih Tzu 6
Domestic Longhair 5
Terrier - Bull - American Pit 5
Bulldog - French 5

Most Reported Reactions

Hypoglycaemia 121
Death by euthanasia 82
Death 75
Vomiting 68
Other abnormal test result NOS 61
Lethargy (see also Central nervous system depression in 'Neurological') 52
Elevated total bilirubin 52
Leucocytosis NOS 44
Elevated alanine aminotransferase (ALT) 44
Anorexia 43
Dehydration 43
Not eating 42

Outcome Breakdown

Euthanized
81 (32.4%)
Died
76 (30.4%)
Ongoing
46 (18.4%)
Recovered/Normal
27 (10.8%)
Outcome Unknown
20 (8.0%)

Dextrose Adverse Event Insights

244 reports name Dextrose; 155 recorded a death outcome (63.5% of reported events, not a population-level mortality rate). Active ingredient: Dextrose. Administration routes: Unknown, Intravenous, Parenteral, Oral.

By species: Dog (172 reports), Cat (71 reports), Rabbit (1 reports). By breed: Domestic Shorthair (48), Retriever - Labrador (23), Chihuahua (11).

Leading clinical signs: Hypoglycaemia (121), Death by euthanasia (82), Death (75), Vomiting (68). Outcome, 250 coded reports: Euthanized leads at 32.4%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.